Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta
Bs. Lee et Ra. Nowak, Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta, J CLIN END, 86(2), 2001, pp. 913-920
Transforming growth factor-betas (TGF betas) are multifunctional peptides t
hat regulate growth and differentiation in a variety of cells. The goals of
this study were to compare expression of the TGF beta isoforms in normal m
yometrium and benign leiomyoma tumors of the uterus and to examine the effe
cts of TGF betas on cell proliferation and collagen production by these cel
ls in vitro. Myometrium and leiomyoma tissues were obtained from patients u
ndergoing elective hysterectomies. Tissues were processed for ribonucleic a
cid (RNA) and were also established as primary cell cultures. Northern blot
analysis showed that the levels of TGF beta1 messenger RNAs (mRNAs) were s
imilar between leiomyoma and myometrium, whereas leiomyoma showed 5-fold hi
gher levels of expression of TGF beta3 mRNA than autologous myometrium. Exp
ression of TGF beta3 protein detected by immunohistochemistry was much more
intense in leiomyoma tissues than in corresponding myometrium. Levels of b
oth TGF beta1 and TGF beta3 increased with increasing cell density for leio
myoma and myometrium smooth muscle cells cultured in vitro. Effects of TGF
beta1 and TGF beta3 on cell proliferation were assessed by measuring change
s in DNA synthesis with the tritiated thymidine incorporation assay. The do
ses of TGF betas tested were 0, 0.1, 1.0, and 10.0 ng/mL. All three doses o
f TGF beta1 and TGF beta3 inhibited DNA synthesis in myometrium smooth musc
le cells by 31-54%. Concomitant treatment with an immunoneutralizing antibo
dy to TGF beta1-3 reversed this inhibitory effect. In contrast, TGF beta1 h
ad no effect on leiomyoma smooth muscle cells, whereas TGF beta3 increased
DNA synthesis by leiomyoma cells. Combined treatment with the immunoneutral
izing antibody prevented this increase. Treatment of leiomyoma and myometri
al cells with the TGF beta immunoneutralizing antibody for 24 h caused a 45
-60% reduction in collagen type I and type III mRNA levels, suggesting that
endogenous TGF betas are important for collagen production. These results
support the hypothesis that alterations in the TGF beta system produce loss
of sensitivity to the antiproliferative effects of TGF beta, and increased
expression of TGF beta3 may contribute to the growth of these tumors.